Methylphenidate, Rivastigmine or Haloperidol in Hypoactive Delirium in Intensive Care Patients

NCT00599287 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
80
Enrollment
OTHER
Sponsor class

Stopped Inclusion rate too low due to a lack of eligible patients and difficulties obtaining informed consent.

Conditions

Interventions

Sponsor

UMC Utrecht